PHP293 - ORPHAN DRUGS IN GERMANY - LESSONS LEARNED FROM AMNOG, BEST AND WORST PRACTICES AND STRATEGIC IMPLICATIONS
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.1187
https://www.valueinhealthjournal.com/article/S1098-3015(18)34489-9/fulltext
Section Title :
Section Order :
589
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34489-9&doi=10.1016/j.jval.2018.09.1187